Free Trial

SurgePays (NASDAQ:SURG) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

SurgePays logo with Computer and Technology background

Shares of SurgePays, Inc. (NASDAQ:SURG - Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.11 and traded as high as $3.15. SurgePays shares last traded at $3.06, with a volume of 33,560 shares trading hands.

Wall Street Analyst Weigh In

SURG has been the subject of a number of research analyst reports. Ascendiant Capital Markets raised their target price on SurgePays from $8.75 to $9.00 and gave the company a "buy" rating in a report on Monday, June 16th. Wall Street Zen raised shares of SurgePays from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd.

Read Our Latest Stock Analysis on SURG

SurgePays Stock Performance

The firm has a market capitalization of $64.50 million, a price-to-earnings ratio of -1.13 and a beta of 0.46. The firm has a 50 day moving average price of $2.89 and a 200-day moving average price of $2.11. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.72 and a quick ratio of 1.41.

SurgePays (NASDAQ:SURG - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The medical equipment provider reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.40) by $0.02. SurgePays had a negative return on equity of 206.01% and a negative net margin of 136.37%. The business had revenue of $10.58 million during the quarter, compared to analysts' expectations of $9.80 million. During the same quarter last year, the business posted $0.07 EPS. As a group, sell-side analysts expect that SurgePays, Inc. will post -1.66 earnings per share for the current fiscal year.

Institutional Investors Weigh In On SurgePays

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Geode Capital Management LLC grew its stake in shares of SurgePays by 5.5% during the fourth quarter. Geode Capital Management LLC now owns 156,115 shares of the medical equipment provider's stock worth $278,000 after purchasing an additional 8,097 shares in the last quarter. D.A. Davidson & CO. purchased a new position in shares of SurgePays in the 1st quarter valued at about $25,000. Goldman Sachs Group Inc. purchased a new position in shares of SurgePays in the 1st quarter valued at about $28,000. Renaissance Technologies LLC raised its position in shares of SurgePays by 43.6% during the 4th quarter. Renaissance Technologies LLC now owns 49,400 shares of the medical equipment provider's stock worth $88,000 after acquiring an additional 15,000 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft purchased a new stake in SurgePays during the first quarter worth approximately $35,000. 6.94% of the stock is currently owned by institutional investors and hedge funds.

About SurgePays

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Featured Stories

Should You Invest $1,000 in SurgePays Right Now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines